Statement of Cash Flows (USD $)	6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012
Cash flows from operating activities:
Net income attributable to common shareholders	$ (35,204)	$ 6,667,172
Adjustments to reconcile net income to net cash used in operating activities net of changes in assets and liabilities resulting from the sales and purchases of subsidiaries:
Amortization (accretion) of investments	(1,462,254)	(874,286)
Realized investment gains, net	(621,564)	(10,982,695)
Unrealized trading gains included in income	(49,545)	(167,251)
Amortization of deferred policy acquisition costs	28,216	31,024
Amortization of cost of insurance acquired	532,176	572,750
Depreciation	640,571	638,394
Net income attributable to noncontrolling interest	342,783	426,378
Charges for mortality and administration of universal life and annuity products	(3,458,497)	(3,541,227)
Interest credited to account balances	2,662,628	2,551,509
Change in accrued investment income (loss)	138,634	(1,418,809)
Change in reinsurance receivables	1,072,113	1,486,180
Change in policy liabilities and accruals	(2,642,960)	(2,191,530)
Change in income taxes receivable (payable)	(3,463,692)	2,526,735
Change in other assets and liabilities, net	633,298	1,723
Net cash provided by (used in) operating activities	(5,683,297)	(4,273,933)
Proceeds from investments sold and matured:
Fixed maturities available for sale	21,247,954	79,045,533
Equity securities available for sale	238,330	559,865
Trading securities	23,753,619	7,148,992
Mortgage loans	9,004,089	2,583,581
Discounted mortgage loans	3,898,888	3,156,105
Real estate	4,063,257	8,808,213
Policy loans	2,029,941	1,982,303
Total proceeds from investments sold and matured	64,236,078	103,284,592
Cost of investments acquired:
Fixed maturities available for sale	(16,132,719)	(120,109,964)
Equity securities available for sale	(8,731,875)	(9,173,511)
Trading securities	(22,140,303)	(6,625,128)
Mortgage loans	(1,435,782)	(15,813,757)
Discounted mortgage loans	(1,436,582)	(6,040,124)
Real estate	(7,829,033)	(6,142,148)
Policy loans	(1,497,536)	(1,499,930)
Payments for (Proceeds from) Other Investing Activities	(25,000)	0
Total cost of investments acquired	(59,228,830)	(165,404,562)
Sale of property and equipment	0	17,440
Net cash used in investing activities	5,007,248	(62,102,530)
Cash flows from financing activities:
Policyholder contract deposits	2,884,121	2,990,832
Policyholder contract withdrawals	(2,940,308)	(3,364,427)
Proceeds from notes payable/line of credit	0	1,281,000
Payments of principal on notes payable/line of credit	(202,919)	(1,221,425)
Purchase of treasury stock	(103,625)	(571,380)
Distributions to minority interests of consolidated subsidiaries	0	(14,000)
Net cash provided by (used in) financing activities	(362,731)	(899,400)
Net increase (decrease) in cash and cash equivalents	(1,038,780)	(67,275,863)
Cash and cash equivalents at beginning of period	23,321,246	82,925,675
Cash and cash equivalents at end of period	$ 22,282,466	$ 15,649,812